A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction
{{output}}
The bromodomain and extra-terminal domain (BET) family of proteins, especially bromodomain-containing protein 4 (BRD4), has emerged as exciting anti-tumor targets due to their important roles in epigenetic regulation. Therefore, the discovery of BET inhibitors... ...
